Usana Health Sciences Income Statement (2010-2026) | USNA

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Jul2021	Oct2021	Jan2022	Apr2022	Jul2022	Oct2022	Dec2022	Apr2023	Jul2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Jan2026	Apr2026
Revenue & cost
Revenue (Quarter)	336.84M	274.35M	362.34M	272.87M	264.47M	233.30M	227.96M	248.36M	238.20M	213.37M	221.08M	227.80M	212.87M	200.22M	213.61M	249.54M	235.85M	213.67M	226.20M	250.22M
Cost of Revenue (Quarter)	57.01M	50.72M	67.81M	51.38M	49.52M	46.56M	46.43M	48.52M	43.33M	42.53M	42.32M	43.07M	40.33M	39.26M	38.55M	52.45M	50.18M	48.81M	49.41M	59.44M
Gross Profit (Quarter)	279.82M	223.64M	294.53M	221.48M	214.96M	186.74M	181.53M	199.84M	194.88M	170.84M	178.76M	184.73M	172.54M	160.96M	175.06M	197.09M	185.66M	164.85M	176.79M	190.78M
Operating items
Selling, General & Administrative (Quarter)	72.24M	66.64M	87.09M	68.80M	66.39M	66.02M	61.10M	66.93M	68.10M	63.30M	58.66M	64.30M	64.33M	61.30M	73.35M	91.44M	81.91M	85.95M	78.08M	88.25M
Other Operating Expenses (Quarter)	153.86M	116.22M	161.20M	119.62M	119.20M	98.09M	97.88M	106.07M	102.38M	89.93M	95.88M	95.76M	90.37M	84.07M	93.50M	89.98M	87.04M	77.68M	94.89M	88.65M
Operating Expenses (Quarter)	226.10M	182.87M	248.29M	188.42M	185.59M	164.11M	158.98M	173.00M	170.48M	153.23M	154.54M	160.06M	154.70M	145.36M	166.85M	181.42M	168.95M	163.63M	172.97M	176.91M
Operating Income (Quarter)	53.72M	40.77M	46.24M	33.07M	29.37M	22.63M	22.55M	26.84M	24.40M	17.61M	24.22M	24.67M	17.84M	15.60M	8.21M	15.67M	16.72M	1.22M	3.82M	13.87M
EBIT (Quarter)	53.72M	40.77M	46.24M	33.07M	29.37M	22.63M	22.55M	26.84M	24.40M	17.61M	24.22M	24.67M	17.84M	15.60M	8.21M	15.67M	16.72M	1.22M	3.82M	13.87M
Non-operating items
Interest & Investment Income (Quarter)	0.68M	0.49M	0.64M	0.74M	0.67M	0.92M	1.46M	1.77M	2.22M	2.73M	2.90M	2.68M	2.76M	3.14M	2.74M	0.72M	0.62M	0.58M	0.49M	0.44M
Other Non Operating Income (Quarter)	-0.07M	-0.89M	-1.21M	-0.49M	-0.64M	-0.29M	-1.18M	-0.09M	0.23M	0.23M	-0.37M	-0.19M	-0.35M	-0.09M	-0.39M	0.76M	1.74M	0.04M	-0.01M	1.39M
Non Operating Income (Quarter)	0.59M	-0.89M	0.99M	-0.49M	-0.06M	-0.29M	-3.35M	-0.09M	0.23M	0.23M	-0.37M	-0.19M	2.36M	-0.09M	-8.82M	1.07M	1.74M	0.57M	-0.01M	1.39M
Net income details
EBT (Quarter)	54.31M	40.35M	47.23M	33.29M	29.31M	23.22M	22.80M	28.50M	26.81M	20.53M	26.61M	27.11M	20.20M	18.61M	10.43M	16.74M	18.82M	1.79M	4.18M	15.46M
Tax Provisions (Quarter)	16.08M	13.02M	15.76M	10.82M	10.15M	8.29M	10.01M	10.12M	9.52M	9.18M	9.85M	10.57M	9.77M	8.00M	5.95M	7.45M	8.37M	8.46M	5.77M	8.51M
Profit After Tax (Quarter)	38.23M	27.33M	31.47M	22.47M	19.16M	14.93M	12.79M	18.38M	17.29M	11.35M	16.77M	16.54M	10.43M	10.61M	4.48M	9.40M	9.65M	-6.66M	-2.31M	7.51M
Income from Non-Controlling Interests (Quarter)															0.03M	-0.11M	0.79M	-0.14M	0.18M	-0.56M
Income from Continuing Operations (Quarter)	38.23M	27.33M	31.47M	22.47M	19.16M	14.93M	12.79M	18.38M	17.29M	11.35M	16.77M	16.54M	10.43M	10.61M	4.48M	9.29M	10.44M	-6.66M	-1.59M	6.96M
Consolidated Net Income (Quarter)	38.23M	27.33M	31.47M	22.47M	19.16M	14.93M	12.79M	18.38M	17.29M	11.35M	16.77M	16.54M	10.43M	10.61M	4.48M	9.29M	10.44M	-6.66M	-1.59M	6.96M
Income towards Parent Company (Quarter)	38.23M	27.33M	31.47M	22.47M	19.16M	14.93M	12.79M	18.38M	17.29M	11.35M	16.77M	16.54M	10.43M	10.61M	4.48M	9.29M	10.44M	-6.66M	-1.59M	6.96M
Net Income towards Common Stockholders (Quarter)	38.23M	27.33M	20.32M	22.47M	19.16M	14.93M	12.79M	18.38M	17.29M	11.35M	16.77M	16.54M	10.43M	10.61M	4.48M	9.29M	10.44M	-6.66M	-1.59M	6.96M
Additional items
EPS (Basic) (Quarter)	1.89	1.37	1.77	1.16	1.00	0.78	0.66	0.95	0.89	0.59	0.87	0.86	0.55	0.56	0.23	0.49	0.52	-0.36	-0.09	0.41
EPS (Weighted Average and Diluted) (Quarter)	1.87	1.36	1.73	1.15	1.00	0.78	0.66	0.95	0.89	0.59	0.87	0.86	0.54	0.56	0.23	0.49	0.52	-0.36	-0.09	0.41
Shares Outstanding (Weighted Average) (Quarter)	20.25M	20.37M	20.15M	19.35M	19.28M	19.22M	19.25M	19.28M	19.30M	19.25M	19.25M	19.17M	19.12M	19.11M	19.10M	19.05M	18.78M	18.29M	18.54M	18.40M
Shares Outstanding (Diluted Average) (Quarter)	20.77M	20.57M	20.34M	19.48M	19.36M	19.25M	19.31M	19.33M	19.43M	19.38M	19.34M	19.30M	19.23M	19.18M	19.16M	19.09M	18.54M	18.67M	18.57M	18.41M
EBITDA (Quarter)	41.82M	26.81M	34.73M	21.23M	10.48M	4.39M	20.01M	20.14M	9.85M	9.60M	23.30M	11.64M	8.52M	17.42M	-4.52M	9.21M	13.06M	-6.60M	0.80M	8.70M
Interest Expenses (Quarter)	0.02M	0.02M	-1.56M	0.03M	0.10M	0.03M	0.03M	0.03M	0.04M	0.04M	0.14M	0.05M	0.05M	0.05M	0.13M	0.41M	0.26M	0.05M	0.12M	0.24M
Tax Rate (Quarter)	29.60%	32.27%	33.36%	32.50%	34.64%	35.72%	43.89%	35.50%	35.50%	44.73%	37.00%	39.00%	48.36%	43.00%	57.00%	44.50%	44.50%	471.35%	138.19%	55.00%

Research Tools

Usana Health Sciences Income Statement (2010-2026) | USNA

Create an account

Sign In

Reset Password